# DHI Group, Inc.: overview DHX · NYSE · CIK 1393883 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dhx.md) · [Financials](/companies/dhx/financials.md) · [Filings](/companies/dhx/filings.md) · [Insiders](/companies/dhx/insiders.md) Latest reported revenue: [$31.3m](/filings/0001393883-26-000108.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001393883-26-000108). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [35.3](/filings/0001393883-25-000120.md) | [34.8 d](/filings/0001393883-26-000041.md) | [32.3](/filings/0001393883-26-000070.md) | [32.0](/filings/0001393883-26-000108.md) | [32.1](/filings/0001393883-25-000120.md) | [31.4 d](/filings/0001393883-26-000041.md) | [29.7](/filings/0001393883-26-000070.md) | [31.3](/filings/0001393883-26-000108.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [1.8%](/filings/0001393883-25-000120.md) | [5.0% d](/filings/0001393883-26-000041.md) | [(28.7%)](/filings/0001393883-26-000070.md) | [(3.9%)](/filings/0001393883-26-000108.md) | [(14.0%)](/filings/0001393883-25-000120.md) | [11.7% d](/filings/0001393883-26-000041.md) | [10.3%](/filings/0001393883-26-000070.md) | [12.2%](/filings/0001393883-26-000108.md) | | Net margin | % | [(0.6%)](/filings/0001393883-25-000120.md) | [2.9% d](/filings/0001393883-26-000041.md) | [(30.2%)](/filings/0001393883-26-000070.md) | [(2.6%)](/filings/0001393883-26-000108.md) | [(13.3%)](/filings/0001393883-25-000120.md) | [4.3% d](/filings/0001393883-26-000041.md) | [5.2%](/filings/0001393883-26-000070.md) | [8.3%](/filings/0001393883-26-000108.md) | | Diluted EPS | $ per share | [0.00](/filings/0001393883-25-000120.md) | not reported | [(0.21)](/filings/0001393883-26-000070.md) | [(0.02)](/filings/0001393883-26-000108.md) | [(0.10)](/filings/0001393883-25-000120.md) | not reported | [0.04](/filings/0001393883-26-000070.md) | [0.06](/filings/0001393883-26-000108.md) | | Free cash flow | $m | [2.3 d](/filings/0001393883-25-000120.md) | [1.6 d](/filings/0001393883-26-000041.md) | [0.1](/filings/0001393883-26-000070.md) | [4.8 d](/filings/0001393883-26-000108.md) | [3.2 d](/filings/0001393883-25-000120.md) | [5.7 d](/filings/0001393883-26-000041.md) | [6.8](/filings/0001393883-26-000070.md) | [4.5 d](/filings/0001393883-26-000108.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [120](/filings/0001393883-24-000040.md) | [150](/filings/0001393883-25-000041.md) | [152](/filings/0001393883-26-000041.md) | [142](/filings/0001393883-26-000041.md) | [128](/filings/0001393883-26-000041.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(1.5%)](/filings/0001393883-24-000040.md) | [3.7%](/filings/0001393883-25-000041.md) | [4.1%](/filings/0001393883-26-000041.md) | [4.5%](/filings/0001393883-26-000041.md) | [(8.9%)](/filings/0001393883-26-000041.md) | | Net margin | % | [(24.8%)](/filings/0001393883-24-000040.md) | [2.8%](/filings/0001393883-25-000041.md) | [2.3%](/filings/0001393883-26-000041.md) | [0.2%](/filings/0001393883-26-000041.md) | [(10.6%)](/filings/0001393883-26-000041.md) | | Diluted EPS | $ per share | [(0.64)](/filings/0001393883-24-000040.md) | [0.09](/filings/0001393883-25-000041.md) | [0.08](/filings/0001393883-26-000041.md) | [0.01](/filings/0001393883-26-000041.md) | [(0.30)](/filings/0001393883-26-000041.md) | | Free cash flow | $m | [14.3](/filings/0001393883-24-000040.md) | [18.1](/filings/0001393883-25-000041.md) | [1.1](/filings/0001393883-26-000041.md) | [7.1](/filings/0001393883-26-000041.md) | [13.8](/filings/0001393883-26-000041.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dhx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $12.0m | 3,228,701 | | Reduced −400,426 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $10.2m | 2,755,966 | | Reduced −66,578 | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $8.8m | 2,374,027 | | Unchanged | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $8.8m | 2,374,027 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $7.5m | 2,013,229 | | Added +211,900 | | [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $6.8m | 1,837,333 | | Reduced −34,923 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.9m | 1,590,538 | | Reduced −136,498 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $4.1m | 1,098,945 | | Added +291,303 | | [SEI INVESTMENTS CO](/funds/350894.md) | 2026-06-30 | $3.2m | 870,191 | | Reduced −934,090 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.0m | 817,543 | | Reduced −9,292 | ## Recent filings [All 1,352 filings](/companies/dhx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-05 | 16:13 ET | [10-Q](/filings/0001393883-26-000108.md) | Quarterly report, period 2026-06-30 | 0001393883-26-000108 | | 2026-08-05 | 16:09 ET | [8-K](/filings/0001393883-26-000106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001393883-26-000106 | | 2026-05-19 | 16:17 ET | [8-K](/filings/0001393883-26-000094.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001393883-26-000094 | | 2026-05-05 | 16:31 ET | [10-Q](/filings/0001393883-26-000070.md) | Quarterly report, period 2026-03-31 | 0001393883-26-000070 | | 2026-05-05 | 16:17 ET | [8-K](/filings/0001393883-26-000068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001393883-26-000068 | | 2026-04-06 | 16:07 ET | [8-K](/filings/0001393883-26-000062.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001393883-26-000062 | | 2026-04-02 | 16:10 ET | [DEF 14A](/filings/0001393883-26-000058.md) | Proxy statement, period 2026-05-15 | 0001393883-26-000058 | | 2026-03-02 | 16:13 ET | [8-K](/filings/0001393883-26-000053.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393883-26-000053 | | 2026-02-26 | 16:14 ET | [8-K](/filings/0001393883-26-000049.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001393883-26-000049 | | 2026-02-23 | 16:24 ET | [8-K](/filings/0001393883-26-000045.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001393883-26-000045 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001393883-26-000041.md), filed Feb 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bdfe1647-599c-4834-912f-adabded5d96a) ## About the filer - CIK: 1393883 - Tickers: DHX - Exchange: NYSE - SIC code: 7389 Services-Business Services, NEC - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.